Skip to search formSkip to main contentSkip to account menu

ferucarbotran

Known as: carboxydextran-coated superparamagnetic iron oxide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Organic Chemicalsferumoxides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Delayed hepatic signal recovery on ferucarbotran-enhanced magnetic resonance images: an experimental study in rat livers with gadolinium chloride-induced Kupffer cell damage
ObjectiveHepatic signal recovery, rather than reduction, in ferucarbotran-enhanced magnetic resonance imaging (MRI) is a… 
2012
2012
Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.
OBJECTIVES Our aim was to determine whether ablated liver parenchyma surrounding a tumour can be assessed by MRI with… 
2012
2012
Feasibility of semiquantitative liver perfusion assessment by ferucarbotran bolus injection in double‐contrast hepatic MRI
To evaluate the feasibility of semiquantitative measurement of liver perfusion from analysis of ferucarbotran induced signal… 
2009
2009
Differentiation of well‐differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: Value of SPIO‐enhanced MR imaging at 3.0 Tesla
To determine the diagnostic value of superparamagnetic iron oxide (SPIO)‐enhanced MRI for the differentiation of well… 
2009
2009
Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran.
We compared the diagnostic efficacy of gadolinium (Gd)-enhanced MRI with that of Gd-enhanced MRI after administration of… 
Highly Cited
2007
Highly Cited
2007
Superparamagnetic iron oxide (SPIO)‐enhanced liver MRI with ferucarbotran: Efficacy for characterization of focal liver lesions
To evaluate the efficacy of ferucarbotran in T2‐weighted (T2W) fast spin‐echo (FSE) and T2*W gradient‐echo (GRE) sequences for… 
Review
2007
Review
2007
Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions.
AIM To evaluate the efficacy of ferucarbotran-enhanced MR imaging in the detection of focal hepatic lesions compared to plain and… 
2006
2006
Comparison of Gadolinium-BOPTA and Ferucarbotran-Enhanced Three-Dimensional T1-Weighted Dynamic Liver Magnetic Resonance Imaging in the Same Patient
Objectives:We sought to compare signal changes using Ferucarbotran and gadobenate dimeglumine (Gd-BOPTA) in dynamic 3D T1… 
2006
2006
Detection of hepatic metastases using ferucarbotran‐enhanced MR imaging: Feasibility and diagnostic accuracy of three‐dimensional sensitivity‐encoding water‐excitation multishot echo‐planar sequence…
To evaluate the diagnostic accuracy of a ferucarbotran‐enhanced three‐dimensional sensitivity‐encoding water‐excitation multishot… 
2006
2006
Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions.
OBJECTIVE The objective of our study was to determine the optimal TE for superparamagnetic iron oxide (SPIO)-enhanced gradient… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)